share_log

罗欣药业(002793.SZ):一季度净亏损3666.16万元

Luoxin Pharmaceutical (002793.SZ): Net loss of 366.616 million yuan in the first quarter

Gelonghui Finance ·  Apr 26 05:39

Gelonghui, April 26 | Luoxin Pharmaceutical (002793.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 689 million yuan, up 3.97% year on year; net profit attributable to shareholders of listed companies - 366.616 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 389.5599 million yuan; basic earnings per share - 0.03 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment